C16ORF57 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.777400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.202440E-01
Normal-vs-Stage2
5.357800E-01
Normal-vs-Stage3
2.872400E-01
Normal-vs-Stage4
6.139200E-01
Stage1-vs-Stage2
1.715960E-01
Stage1-vs-Stage3
8.894200E-01
Stage1-vs-Stage4
3.427800E-02
Stage2-vs-Stage3
1.985350E-01
Stage2-vs-Stage4
1.756230E-01
Stage3-vs-Stage4
1.304010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.565200E-01
Normal-vs-AfricanAmerican
3.725000E-01
Normal-vs-Asian
6.006600E-01
Caucasian-vs-AfricanAmerican
7.936200E-01
Caucasian-vs-Asian
7.198800E-01
AfricanAmerican-vs-Asian
6.403600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.520000E-01
Normal-vs-Female
4.009000E-01
Male-vs-Female
4.644400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.893200E-01
Normal-vs-Age(41-60Yrs)
8.975000E-01
Normal-vs-Age(61-80Yrs)
3.253800E-01
Normal-vs-Age(81-100Yrs)
3.254200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.437000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.273000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.681200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.455500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.567430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.969600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.744400E-01
Normal-vs-Daily Drinker
4.002000E-01
Normal-vs-Weekly Drinker
8.357400E-01
Normal-vs-Occasional Drinker
9.776400E-01
Normal-vs-Social Drinker
5.452800E-01
Non Drinker-vs-Daily Drinker
9.241000E-01
Non Drinker-vs-Weekly Drinker
8.848500E-02
Non Drinker-vs-Occasional Drinker
3.695800E-02
Non Drinker-vs-Social Drinker
3.993600E-01
Daily Drinker-vs-Weekly Drinker
1.837990E-01
Daily Drinker-vs-Occasional Drinker
9.701500E-02
Daily Drinker-vs-Social Drinker
5.346600E-01
Weekly Drinker-vs-Occasional Drinker
7.730600E-01
Weekly Drinker-vs-Social Drinker
4.505400E-01
Occasional Drinker-vs-Social Drinker
3.025600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.790400E-01
Normal-vs-Grade 2
7.321800E-01
Normal-vs-Grade 3
6.981600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.70110000000212E-06
Grade 1-vs-Grade 3
4.38999999999856E-05
Grade 1-vs-Grade 4
9.790400E-01
Grade 2-vs-Grade 3
3.941000E-01
Grade 2-vs-Grade 4
7.321800E-01
Grade 3-vs-Grade 4
6.981600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.022600E-01
Normal-vs-NonDiabetic
4.967400E-01
Diabetic-vs-NonDiabetic
8.811200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.101200E-01
Normal-vs-NoPancreatitis
4.548200E-01
Pancreatitis-vs-NoPancreatitis
6.046500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.039000E-01
Normal-vs-N1
4.867200E-01
N0-vs-N1
9.798600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.443000E-01
Normal-vs-TP53-NonMutant
5.617600E-02
TP53-Mutant-vs-TP53-NonMutant
6.5715000108213E-10
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
